Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonists
Galina Meier(Freie Universität Berlin), Holger Stark(Heinrich Heine University Düsseldorf), Walter Schunack, Fabien Leurquin(University College London), Ulrich Reichert(Freie Universität Berlin), Xavier Ligneau(Inserm), Sigurd Elz, Sven Graßmann(Freie Universität Berlin), C. Robin Ganellin(University College London), Jean‐Charles Schwartz(Inserm), Joachim Apelt(Freie Universität Berlin)
Cited by 108
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
|Nature Medicine|2003|381
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264
Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
|Journal of Pharmacology and Experimental Therapeutics|1998|240